A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and efficacy study of fixed-combination bimatoprost and brimonidine compared with LUMIGAN® and ALPHAGAN® in patients with chronic glaucoma or ocular hypertension.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Brimonidine Tartrate; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Diagnosis of ocular hypertension or glaucoma

• Requires intraocular pressure (IOP)-lowering therapy

Exclusion Criteria:

• Cataract surgery in one eye

• Ocular laser or intraocular surgery within 6 months

• Refractive surgery in either eye

• Anticipated use of contact lenses during the study

• Expected use of artificial tears during the study